Related Experiment Video
Updated: Mar 8, 2026

10:43
Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids
Published on: December 23, 2022
4.1K
Squamous cell carcinoma with enteric adenocarcinomatous differentiation
Patrick O Emanuel1,2, Garrett Desman2, Ben Tallon3,4
1Department of Pathology and Molecular Medicine, University of Auckland, Auckland, New Zealand.
Journal of Cutaneous Pathology
|January 24, 2017
Summary
This study details a rare primary cutaneous squamous cell carcinoma (SCC) exhibiting unusual enteric-type adenocarcinoma and mesenchymal dedifferentiation. This unique presentation highlights significant phenotypic plasticity in skin cancer.
Area of Science:
- Dermatopathology
- Oncology
- Cancer Biology
Background:
- Primary cutaneous squamous cell carcinoma (SCC) is a common skin malignancy.
- Understanding the diverse differentiation pathways of SCC is crucial for accurate diagnosis and treatment.
- Phenotypic plasticity in cancer refers to the ability of tumor cells to alter their characteristics.
Observation:
- A unique case of primary cutaneous squamous cell carcinoma was identified.
- The tumor displayed intermixed enteric-type adenocarcinomatous dedifferentiation.
- A minor component of undifferentiated mesenchymal differentiation was also observed.
Findings:
- This represents the first documented instance of enteric-type adenocarcinomatous dedifferentiation within a cutaneous SCC.
- The co-occurrence of glandular and mesenchymal differentiation in SCC demonstrates remarkable cellular plasticity.
- Histopathological analysis revealed complex tumor morphology.
Implications:
- This case expands the known spectrum of differentiation in cutaneous SCC.
- It suggests that cutaneous SCC may possess a broader potential for phenotypic plasticity than previously recognized.
- Further research is warranted to explore the mechanisms driving this plasticity and its clinical significance.
Related Concept Videos
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Renewal of Intestinal Stem Cells
3.4K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
3.4K
Cancer Cell Migration through Invadopodia
3.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.4K

